Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL
Clinical trial NCT04303520 · UNKNOWN
Trial details
- NCT number
- NCT04303520
- Sponsor
- The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-03
- Primary completion
- 2020-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.